Asepsis-Medical-Logo-Web
  • Home
  • Products
  • News
  • Inquires
    • Contact Us
    • Partnering with Asepsis
  • Company
    • Message from the CEO
    • Leadership Team
    • Patent Grants
    • Incidence of Medical Errors
    • Corporate Responsibility
    • Quality Compliance
    • Terms of Use
  • Home
  • Products
  • News
  • Inquires
    • Contact Us
    • Partnering with Asepsis
  • Company
    • Message from the CEO
    • Leadership Team
    • Patent Grants
    • Incidence of Medical Errors
    • Corporate Responsibility
    • Quality Compliance
    • Terms of Use
Asepsis-Medical-Logo-Web
  • Home
  • Products
  • News
  • Inquires
    • Contact Us
    • Partnering with Asepsis
  • Company
    • Message from the CEO
    • Leadership Team
    • Patent Grants
    • Incidence of Medical Errors
    • Corporate Responsibility
    • Quality Compliance
    • Terms of Use
  • Home
  • Products
  • News
  • Inquires
    • Contact Us
    • Partnering with Asepsis
  • Company
    • Message from the CEO
    • Leadership Team
    • Patent Grants
    • Incidence of Medical Errors
    • Corporate Responsibility
    • Quality Compliance
    • Terms of Use

Posts

June 7, 2016

Asepsis Medical Technologies announces the Notice of Allowance of Australian Patent Application 2013222819

Asepsis Medical Technologies announces the Notice of Allowance of Australian Patent Application 2013222819 for its Safe-T-Dose® combinatorial drug injection kit. The Asepsis’ Calibrated Drug Delivery™

CONTINUE READING
May 19, 2016

Asepsis Medical Technologies announces the USPTO grant of Patent Application 14/059,070

Asepsis Medical Technologies announces the USPTO grant of Patent Application 14/059,070 for its Safe-T-Fuse™ drug infusion system. The Safe-T-Fuse™ is an industry unique infusion container that allows

CONTINUE READING
April 3, 2016

Asepsis announces the USPTO grant of US Patent 9,302,050 for its combinatorial, Calibrated Drug Delivery™ (CDD) platform

Asepsis announces the USPTO grant of U.S. Patent 9,302,050 for its combinatorial, Calibrated Drug Delivery™ (CDD) platform. The 050 patent continuation further enhances the reconstitution aspects of t

CONTINUE READING
February 11, 2016

Independent formative usability studies were completed on the Asepsis pediatric Calibrated Drug Delivery™ Kits in Chicago, Illinois

Independent formative usability studies were completed on the Asepsis pediatric Calibrated Drug Delivery™ Kits in Chicago, Illinois. The ANSI/AAMI HIE75:2009 and ANSI/AAMI/IEC 62366:2007 studies were

CONTINUE READING
September 24, 2015

Asepsis Medical Technologies announces the issuance of U.S. Patent 9,192,723

Asepsis Medical Technologies announces the issuance of U.S. Patent 9,192,723, for its combinatorial drug injection systems. The Asepsis’ Calibrated Drug Delivery™(CDD) platform is designed to eliminat

CONTINUE READING
August 23, 2014

Asepsis announces the patent pending, Vi-Injection Kit™

Asepsis announces the patent pending, Vi-Injection kit™. This combinatorial medicinal injection kit is designed for enhancing the safety and accuracy of a self-injection by a vision impaired (VI) pati

CONTINUE READING
May 5, 2014

Asepsis announces the patent pending Vi-Syringe™

Asepsis announces the patent pending Vi-Syringe™. The Vi-Syringe™ is the world’s first ergonomically designed hypodermic syringe that allows a visually impaired user to independently prepare and admin

CONTINUE READING
February 12, 2014

Asepsis announces the patent pending Momenta-Dose™

Asepsis announces the patent pending Momenta-Dose™, a parenteral injection device designed to administer an injection solely by a user’s applied force and subsequent momentum. This autogenic momentum

CONTINUE READING
January 10, 2014

Asepsis announces the patented, industry unique Safe-T-Syringe®

Asepsis announces the patented, industry unique Safe-T-Syringe®. The unique flat panel displays of the Safe-T-Syringe® comprises a multitude of correlating measurements of its contents without the nee

CONTINUE READING
November 2, 2013

Asepsis announces the patent pending Safe-T-Fuse™

Asepsis announces the patent pending Safe-T-Fuse™. This industry unique infusion bag allows the contents of a standard vial to be quickly introduced to an integrated diluent reservoir without the use

CONTINUE READING
1 2 3 4

Copyright © 2022 Asepsis Medical Technologies, LLC. All rights reserved.